Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis"

Joint Bone Spine

Volumn 76, Issue 1, 2009, Pages 117-118

  Seriolo, Bruno ^a   Paoliono, Sabrina ^a   Ferrone, Carmela ^a   Cutolo, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

anti TNF ; Atheroma; Lipids; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ETANERCEPT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR INHIBITOR;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ACTIVITY; DRUG EFFECT; HUMAN; LETTER; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; HUMANS; HYPERLIPIDEMIAS; LIPIDS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58249090777     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.09.004     Document Type: Letter

References (5)

1. Soubrier M., Jouanel P., Mathieu S., et al. Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis. Joint Bone Spine 75 (2008) 22-24
2. Tam L.S., Tomlinson B., Chu T.T., et al. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol (2007) 1495-1498
3. Vis M., Nurmohamed M.T., Wolbink G., et al. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 252-255
4. Seriolo B., Paolino S., Sulli A., et al. Effects of anti-TNF alpha treatment on lipid profile in patients with active rheumatoid arthritis. Ann N YAcad Sci 1069 (2006) 414-419
5. Dahlqvist S.R., Engstrand S., Berglin E., et al. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy. Scand J Rheumatol 35 (2006) 107-111